1·The clinical and laboratory data of 105 patients with systemic scleroderma (SSC) were analysed.
对105例系统性硬皮病患者的一般情况、临床表现作了详细分析。
2·Systemic scleroderma is a involving skin, bones and joints, digestive, respiratory, heart, kidney, and other systems, multi-organ disease.
系统性硬皮病是一种累及皮肤、骨关节、消化道、呼吸道、心、肾等多系统、多器官的疾病。
3·Objective To discuss clinical curative effect of treatment for systemic scleroderma typed under guidance of the theory of collateral disease.
目的探讨以络病理论为指导辨证分型治疗系统性硬皮病的临床疗效。
4·Objectives To investigate the effect of Gingko bilobate extract(GBE) on cytokines secretion and proliferation of cultured peripheral blood lymphocytes from patients with systemic scleroderma(SSc).
目的研究银杏叶提取物对系统性硬皮病患者体外培养外周血淋巴细胞增殖及其分泌细胞因子的影响。
5·Esophageal motility problems can occur in patients with progressive systemic sclerosis (scleroderma) because the submucosa becomes fibrotic.
系统性硬化(硬皮病)病人食管蠕动障碍，因为黏膜下层纤维化。
6·Scleroderma(or progressive systemic sclerosis):Chronic disease that hardens the skin and fixes it to underlying structures.
硬皮病（亦称进行性全身硬化症）：一种使皮肤变硬并固着于皮下结构的慢性皮肤病。
7·At high magnification, the dermis is expanded by dense collagenous fibrosis in a patient with systemic sclerosis. Immunofluorescence is not helpful with scleroderma.
高倍镜下，系统性硬化症病人真皮中胶原纤维增加使皮肤增厚。免疫荧光检测对硬皮病是无用的。注意：近年来我们往往用系统性硬化症取代名词硬皮病。